Moreno V, Roda D, Pikiel J, Trigo J, et al. Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial. Clin Lung Cancer 2022 May 23. pii: S1525-7304(22)00115.
PMID: 35729005